Linalool is a promising anticancer agent for hepatocellular carcinoma (HCC) therapy via inducing cell apoptosis via Ras, Mitogen-activated protein kinase (MAPKs), and the protein kinase B (AKT)/mammalian target of rapamycin (mTOR)pathways [13]. Here, WNK2 is linked to hepatocellular carcinoma.